Drinking beet juice associated with reduced restenosis after PCI

Published Date: 02 Mar 2023

Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.

Read Full News

Latest News

Migraine With Aura Tied to Higher Stroke Risk

Migraine with aura is associated with an increased risk for ischemic stroke in middle-aged and older adults, particularly men younger than 72 years, a new study shows.

Semaglutide Tablet Wins UK Approval for Weight Loss

The MHRA has approved the UK's first oral semaglutide tablet for obesity, with NHS availability pending a NICE evaluation.

Is Modern Medicine Losing the Art of Listening?

Patients place high value on listening, trust, and clear communication, which are factors that shape adherence, satisfaction, and the overall experience of care.

How ‘Ozempic Mouth’ Became a Thing — and How to Treat It

GLP-1 medications may not directly cause oral health problems, but their mechanisms can. Take a cue from dental experts for insights on how to manage these oral effects.

ANTHEM-HFrEF: What Can We Learn From an Unfinished Trial?

Despite early termination, the ANTHEM-HFrEF trial holds important lessons for investigators.

Extrahepatic Cancer Risk Varies by Liver Disease Subgroups

The risk for extrahepatic cancers varies among subgroups of steatotic liver disease, with the highest risk seen in patients with metabolic dysfunction and alcohol-associated liver disease.

Todays Updates

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

Todays Updates

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

Latest News

Migraine with aura is associated with an increased risk for ischemic stroke in middle-aged and older adults, particularly men younger than 72 years, a new study shows.

The MHRA has approved the UK's first oral semaglutide tablet for obesity, with NHS availability pending a NICE evaluation.

Patients place high value on listening, trust, and clear communication, which are factors that shape adherence, satisfaction, and the overall experience of care.

GLP-1 medications may not directly cause oral health problems, but their mechanisms can. Take a cue from dental experts for insights on how to manage these oral effects.

Despite early termination, the ANTHEM-HFrEF trial holds important lessons for investigators.

The risk for extrahepatic cancers varies among subgroups of steatotic liver disease, with the highest risk seen in patients with metabolic dysfunction and alcohol-associated liver disease.

News All Time

Heat-Related CVD Burden May Nearly Triple by 2050

Rising temperatures are projected to nearly triple the burden of cardiovascular disease in the US by 2050 under a scenario of high emissions of greenhouse gases, a study estimates.

Stroke Treatment Outcomes Vary by Cancer Subtype

Patients with cancer who suffer an acute ischaemic stroke face higher odds of in-hospital death and bleeding after recanalisation therapy, with outcomes varying by cancer subtypes.

Lung Ultrasound Plus CRP May Guide Antibiotic Decisions

Lung ultrasound may help identify a bacterial component in children with acute lower respiratory tract infections and may guide antibiotic decisions when paired with C-reactive protein.

Serum Potassium Concentrations Shape Heart Failure Risk

A meta-analysis identifies the optimal serum potassium range linked to a lower risk for death and hospitalisation in heart failure, with low potassium tied to worse outcomes in HFrEF.

Semaglutide Accepted in Scotland for CV Risk Reduction

The SMC accepted semaglutide for adults with established cardiovascular disease and overweight or obesity, expanding its role beyond weight management.

ACC/AHA Release First-Ever Guideline for CKM Syndrome

New multisociety guidelines shift from obesity alone to a combined construct of cardiovascular-kidney-metabolic health that emphasizes cohesive care management.

Could the Iran Conflict Disrupt MRI Services?

Strikes on Qatar's gas facilities have cut global helium supply, raising concerns for hospitals running older MRI scanners.

Common Metabolic Issue in Women Tied to Mortality Risk

Women with polyendocrine metabolic ovarian syndrome face a higher risk for all-cause mortality than those without the condition, a Finnish study shows.

Rivaroxaban Flops for Prevention in Advanced CKD

Low-dose rivaroxaban failed to cut the high cardiovascular risk in this population in a large randomized trial, contrasting prevention seen in other high-risk populations.

Advance Directives May Reduce Unnecessary End-of-Life Care

Older adults close to death often receive unnecessary end-of-life medical treatments in hospitals.

Obesity Stigma: Is Art History the Fix?

Learning through art history that obesity once denoted prosperity, strength, and beauty, may help healthcare providers treat patients with more compassion, a researcher proposes.

Retatrutide Data Show Dramatic Weight Loss, Other Benefits

Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

Solutions Emerging for Post-GLP-1 Weight Regain

As real-world studies show high rates of GLP-1 discontinuation and rapid weight regain, new interventions may help patients maintain weight loss.

Digoxin Shows Signs of a Heart Failure Revival

New trial data from the Heart Failure 2026 conference suggest that low-dose digoxin may reduce worsening HF events, reigniting debate over digitalis therapy.

FDA Neurology Roundup: May 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Is At-Home, Extended-Release Ketamine Coming to Market Soon?

A new take-home tablet is in development, but will the features that make it attractive blunt the experience that could be part of ketamine’s therapeutic value?

Recommended News For You

The FDA Approves the New Frontline Aggressive ALL Regimen.

Best foot forward—chemo care should include podiatry, say researchers

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

Using MRD Status to Deescalate Multiple Myeloma Therapy

Infection tied to one-fourth of deaths with lower-risk myelodysplastic syndromes

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

Recommended Articles For You

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration 

The Growing Challenge of Haematological Malignancies in Older Adults 

The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium 

Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mindfulness-based interventions are advised by cancer organizations to treat patients' anxiety and depression.

2.

Patients With Melanoma Brain Mets May Fare Better With RT Before Immunotherapy

3.

Alternative breast imaging techniques beyond mammography.

4.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

5.

GLP-1 drugs linked to dramatically lower death rates in colon cancer patients

1.

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

2.

Respiratory Ramifications of Systemic Disease: A Comprehensive Review

3.

Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients

4.

Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care

5.

The Truth About Marijuana and Its Effect on Mental Health 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

5.

Should We Use DARA Up Front As First-Line Therapy in MM?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot